nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—Parkinson's disease—Bromocriptine—type 2 diabetes mellitus	0.74	1	CpDpCtD
Hyoscyamine—Dolasetron—CYP3A4—type 2 diabetes mellitus	0.000547	0.298	CrCbGaD
Hyoscyamine—Granisetron—CYP3A4—type 2 diabetes mellitus	0.0005	0.273	CrCbGaD
Hyoscyamine—Atropine—CYP1A2—type 2 diabetes mellitus	0.000332	0.181	CrCbGaD
Hyoscyamine—Cocaine—CYP3A4—type 2 diabetes mellitus	0.000238	0.13	CrCbGaD
Hyoscyamine—Ipratropium bromide—CYP3A4—type 2 diabetes mellitus	0.000218	0.119	CrCbGaD
Hyoscyamine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000153	0.000795	CcSEcCtD
Hyoscyamine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000153	0.000795	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000153	0.000794	CcSEcCtD
Hyoscyamine—Erythema—Losartan—type 2 diabetes mellitus	0.000152	0.000794	CcSEcCtD
Hyoscyamine—Oedema—Orlistat—type 2 diabetes mellitus	0.000152	0.000792	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000152	0.000792	CcSEcCtD
Hyoscyamine—Headache—Glipizide—type 2 diabetes mellitus	0.000152	0.000791	CcSEcCtD
Hyoscyamine—Palpitations—Metformin—type 2 diabetes mellitus	0.000152	0.00079	CcSEcCtD
Hyoscyamine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000151	0.000789	CcSEcCtD
Hyoscyamine—Shock—Valsartan—type 2 diabetes mellitus	0.000151	0.000788	CcSEcCtD
Hyoscyamine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000151	0.000786	CcSEcCtD
Hyoscyamine—Tension—Losartan—type 2 diabetes mellitus	0.00015	0.000779	CcSEcCtD
Hyoscyamine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00015	0.000779	CcSEcCtD
Hyoscyamine—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000149	0.000778	CcSEcCtD
Hyoscyamine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000149	0.000778	CcSEcCtD
Hyoscyamine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000149	0.000776	CcSEcCtD
Hyoscyamine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000149	0.000775	CcSEcCtD
Hyoscyamine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000149	0.000775	CcSEcCtD
Hyoscyamine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000148	0.000772	CcSEcCtD
Hyoscyamine—Nervousness—Losartan—type 2 diabetes mellitus	0.000148	0.000771	CcSEcCtD
Hyoscyamine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000148	0.000771	CcSEcCtD
Hyoscyamine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000147	0.000768	CcSEcCtD
Hyoscyamine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000147	0.000768	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000147	0.000766	CcSEcCtD
Hyoscyamine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000146	0.000762	CcSEcCtD
Hyoscyamine—Chest pain—Metformin—type 2 diabetes mellitus	0.000146	0.000761	CcSEcCtD
Hyoscyamine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000146	0.000758	CcSEcCtD
Hyoscyamine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000145	0.000758	CcSEcCtD
Hyoscyamine—Syncope—Irbesartan—type 2 diabetes mellitus	0.000145	0.000757	CcSEcCtD
Hyoscyamine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000144	0.000752	CcSEcCtD
Hyoscyamine—Nausea—Glipizide—type 2 diabetes mellitus	0.000144	0.00075	CcSEcCtD
Hyoscyamine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000144	0.000749	CcSEcCtD
Hyoscyamine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000144	0.000749	CcSEcCtD
Hyoscyamine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000144	0.000748	CcSEcCtD
Hyoscyamine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000143	0.000747	CcSEcCtD
Hyoscyamine—Pain—Gliclazide—type 2 diabetes mellitus	0.000143	0.000746	CcSEcCtD
Hyoscyamine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000143	0.000746	CcSEcCtD
Hyoscyamine—Rash—Glimepiride—type 2 diabetes mellitus	0.000143	0.000743	CcSEcCtD
Hyoscyamine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000142	0.000742	CcSEcCtD
Hyoscyamine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000142	0.000742	CcSEcCtD
Hyoscyamine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000142	0.00074	CcSEcCtD
Hyoscyamine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000142	0.00074	CcSEcCtD
Hyoscyamine—Headache—Glimepiride—type 2 diabetes mellitus	0.000142	0.000738	CcSEcCtD
Hyoscyamine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000141	0.000736	CcSEcCtD
Hyoscyamine—Agitation—Losartan—type 2 diabetes mellitus	0.00014	0.00073	CcSEcCtD
Hyoscyamine—Oedema—Metformin—type 2 diabetes mellitus	0.00014	0.00073	CcSEcCtD
Hyoscyamine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00014	0.000727	CcSEcCtD
Hyoscyamine—Flushing—Ramipril—type 2 diabetes mellitus	0.000139	0.000726	CcSEcCtD
Hyoscyamine—Angioedema—Losartan—type 2 diabetes mellitus	0.000139	0.000726	CcSEcCtD
Hyoscyamine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000139	0.000725	CcSEcCtD
Hyoscyamine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000138	0.000719	CcSEcCtD
Hyoscyamine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000138	0.000718	CcSEcCtD
Hyoscyamine—Shock—Metformin—type 2 diabetes mellitus	0.000138	0.000718	CcSEcCtD
Hyoscyamine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000138	0.000716	CcSEcCtD
Hyoscyamine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000137	0.000716	CcSEcCtD
Hyoscyamine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000137	0.000716	CcSEcCtD
Hyoscyamine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000137	0.000714	CcSEcCtD
Hyoscyamine—Vertigo—Losartan—type 2 diabetes mellitus	0.000137	0.000714	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000137	0.000713	CcSEcCtD
Hyoscyamine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000137	0.000712	CcSEcCtD
Hyoscyamine—Syncope—Losartan—type 2 diabetes mellitus	0.000137	0.000712	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000135	0.000706	CcSEcCtD
Hyoscyamine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000135	0.000705	CcSEcCtD
Hyoscyamine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000135	0.000703	CcSEcCtD
Hyoscyamine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000135	0.000703	CcSEcCtD
Hyoscyamine—Palpitations—Losartan—type 2 diabetes mellitus	0.000135	0.000702	CcSEcCtD
Hyoscyamine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000134	0.0007	CcSEcCtD
Hyoscyamine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000134	0.000699	CcSEcCtD
Hyoscyamine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000134	0.000698	CcSEcCtD
Hyoscyamine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000134	0.000697	CcSEcCtD
Hyoscyamine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000134	0.000697	CcSEcCtD
Hyoscyamine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000134	0.000697	CcSEcCtD
Hyoscyamine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000133	0.000693	CcSEcCtD
Hyoscyamine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000133	0.000691	CcSEcCtD
Hyoscyamine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000132	0.00069	CcSEcCtD
Hyoscyamine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000132	0.00069	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000132	0.000689	CcSEcCtD
Hyoscyamine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000132	0.000689	CcSEcCtD
Hyoscyamine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000132	0.000687	CcSEcCtD
Hyoscyamine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000132	0.000685	CcSEcCtD
Hyoscyamine—Constipation—Valsartan—type 2 diabetes mellitus	0.000132	0.000685	CcSEcCtD
Hyoscyamine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000131	0.000683	CcSEcCtD
Hyoscyamine—Hypotension—Metformin—type 2 diabetes mellitus	0.000131	0.000682	CcSEcCtD
Hyoscyamine—Erythema—Ramipril—type 2 diabetes mellitus	0.000131	0.000681	CcSEcCtD
Hyoscyamine—Shock—Irbesartan—type 2 diabetes mellitus	0.00013	0.000678	CcSEcCtD
Hyoscyamine—Pain—Orlistat—type 2 diabetes mellitus	0.00013	0.000677	CcSEcCtD
Hyoscyamine—Chest pain—Losartan—type 2 diabetes mellitus	0.00013	0.000676	CcSEcCtD
Hyoscyamine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00013	0.000676	CcSEcCtD
Hyoscyamine—Anxiety—Losartan—type 2 diabetes mellitus	0.000129	0.000674	CcSEcCtD
Hyoscyamine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000129	0.000672	CcSEcCtD
Hyoscyamine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000129	0.00067	CcSEcCtD
Hyoscyamine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000129	0.000669	CcSEcCtD
Hyoscyamine—Tension—Ramipril—type 2 diabetes mellitus	0.000128	0.000668	CcSEcCtD
Hyoscyamine—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000128	0.000667	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000128	0.000666	CcSEcCtD
Hyoscyamine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000128	0.000666	CcSEcCtD
Hyoscyamine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000128	0.000665	CcSEcCtD
Hyoscyamine—Nervousness—Ramipril—type 2 diabetes mellitus	0.000127	0.000661	CcSEcCtD
Hyoscyamine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000127	0.000661	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000126	0.000655	CcSEcCtD
Hyoscyamine—Confusional state—Losartan—type 2 diabetes mellitus	0.000125	0.000654	CcSEcCtD
Hyoscyamine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000125	0.000653	CcSEcCtD
Hyoscyamine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000125	0.000651	CcSEcCtD
Hyoscyamine—Somnolence—Metformin—type 2 diabetes mellitus	0.000125	0.000649	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000124	0.000648	CcSEcCtD
Hyoscyamine—Oedema—Losartan—type 2 diabetes mellitus	0.000124	0.000648	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000124	0.000648	CcSEcCtD
Hyoscyamine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000124	0.000644	CcSEcCtD
Hyoscyamine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000123	0.000643	CcSEcCtD
Hyoscyamine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000123	0.000642	CcSEcCtD
Hyoscyamine—Shock—Losartan—type 2 diabetes mellitus	0.000122	0.000638	CcSEcCtD
Hyoscyamine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000122	0.000637	CcSEcCtD
Hyoscyamine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000122	0.000634	CcSEcCtD
Hyoscyamine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000121	0.000633	CcSEcCtD
Hyoscyamine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000121	0.000631	CcSEcCtD
Hyoscyamine—Fatigue—Metformin—type 2 diabetes mellitus	0.000121	0.000629	CcSEcCtD
Hyoscyamine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000121	0.000629	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.00012	0.000627	CcSEcCtD
Hyoscyamine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00012	0.000626	CcSEcCtD
Hyoscyamine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00012	0.000626	CcSEcCtD
Hyoscyamine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00012	0.000626	CcSEcCtD
Hyoscyamine—Agitation—Ramipril—type 2 diabetes mellitus	0.00012	0.000626	CcSEcCtD
Hyoscyamine—Constipation—Metformin—type 2 diabetes mellitus	0.00012	0.000624	CcSEcCtD
Hyoscyamine—Angioedema—Ramipril—type 2 diabetes mellitus	0.000119	0.000622	CcSEcCtD
Hyoscyamine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000119	0.000618	CcSEcCtD
Hyoscyamine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000118	0.000617	CcSEcCtD
Hyoscyamine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000118	0.000614	CcSEcCtD
Hyoscyamine—Rash—Glyburide—type 2 diabetes mellitus	0.000118	0.000612	CcSEcCtD
Hyoscyamine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000118	0.000612	CcSEcCtD
Hyoscyamine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000117	0.000612	CcSEcCtD
Hyoscyamine—Vertigo—Ramipril—type 2 diabetes mellitus	0.000117	0.000612	CcSEcCtD
Hyoscyamine—Syncope—Ramipril—type 2 diabetes mellitus	0.000117	0.000611	CcSEcCtD
Hyoscyamine—Headache—Glyburide—type 2 diabetes mellitus	0.000117	0.000609	CcSEcCtD
Hyoscyamine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000116	0.000606	CcSEcCtD
Hyoscyamine—Hypotension—Losartan—type 2 diabetes mellitus	0.000116	0.000606	CcSEcCtD
Hyoscyamine—Palpitations—Ramipril—type 2 diabetes mellitus	0.000116	0.000602	CcSEcCtD
Hyoscyamine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000115	0.000601	CcSEcCtD
Hyoscyamine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000115	0.000599	CcSEcCtD
Hyoscyamine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000115	0.000597	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000115	0.000597	CcSEcCtD
Hyoscyamine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000114	0.000594	CcSEcCtD
Hyoscyamine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000113	0.00059	CcSEcCtD
Hyoscyamine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000113	0.00059	CcSEcCtD
Hyoscyamine—Pain—Irbesartan—type 2 diabetes mellitus	0.000113	0.000589	CcSEcCtD
Hyoscyamine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000113	0.000589	CcSEcCtD
Hyoscyamine—Insomnia—Losartan—type 2 diabetes mellitus	0.000113	0.000586	CcSEcCtD
Hyoscyamine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000112	0.000583	CcSEcCtD
Hyoscyamine—Urticaria—Metformin—type 2 diabetes mellitus	0.000111	0.00058	CcSEcCtD
Hyoscyamine—Chest pain—Ramipril—type 2 diabetes mellitus	0.000111	0.00058	CcSEcCtD
Hyoscyamine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000111	0.000578	CcSEcCtD
Hyoscyamine—Anxiety—Ramipril—type 2 diabetes mellitus	0.000111	0.000578	CcSEcCtD
Hyoscyamine—Nausea—Glyburide—type 2 diabetes mellitus	0.000111	0.000577	CcSEcCtD
Hyoscyamine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000111	0.000577	CcSEcCtD
Hyoscyamine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000111	0.000577	CcSEcCtD
Hyoscyamine—Somnolence—Losartan—type 2 diabetes mellitus	0.000111	0.000576	CcSEcCtD
Hyoscyamine—Asthenia—Valsartan—type 2 diabetes mellitus	0.00011	0.000575	CcSEcCtD
Hyoscyamine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.00011	0.000571	CcSEcCtD
Hyoscyamine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000109	0.000568	CcSEcCtD
Hyoscyamine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000109	0.000568	CcSEcCtD
Hyoscyamine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000109	0.000567	CcSEcCtD
Hyoscyamine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000109	0.000567	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000108	0.000563	CcSEcCtD
Hyoscyamine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000108	0.00056	CcSEcCtD
Hyoscyamine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000108	0.00056	CcSEcCtD
Hyoscyamine—Fatigue—Losartan—type 2 diabetes mellitus	0.000107	0.000559	CcSEcCtD
Hyoscyamine—Oedema—Ramipril—type 2 diabetes mellitus	0.000107	0.000556	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000107	0.000556	CcSEcCtD
Hyoscyamine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000106	0.000555	CcSEcCtD
Hyoscyamine—Pain—Losartan—type 2 diabetes mellitus	0.000106	0.000554	CcSEcCtD
Hyoscyamine—Constipation—Losartan—type 2 diabetes mellitus	0.000106	0.000554	CcSEcCtD
Hyoscyamine—Rash—Gliclazide—type 2 diabetes mellitus	0.000106	0.00055	CcSEcCtD
Hyoscyamine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000106	0.000549	CcSEcCtD
Hyoscyamine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000105	0.000548	CcSEcCtD
Hyoscyamine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000105	0.000547	CcSEcCtD
Hyoscyamine—Shock—Ramipril—type 2 diabetes mellitus	0.000105	0.000547	CcSEcCtD
Hyoscyamine—Headache—Gliclazide—type 2 diabetes mellitus	0.000105	0.000546	CcSEcCtD
Hyoscyamine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000105	0.000544	CcSEcCtD
Hyoscyamine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000105	0.000544	CcSEcCtD
Hyoscyamine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000104	0.000542	CcSEcCtD
Hyoscyamine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000104	0.000542	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000103	0.000537	CcSEcCtD
Hyoscyamine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000103	0.000534	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000102	0.00053	CcSEcCtD
Hyoscyamine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000102	0.00053	CcSEcCtD
Hyoscyamine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000101	0.000524	CcSEcCtD
Hyoscyamine—Asthenia—Metformin—type 2 diabetes mellitus	0.000101	0.000524	CcSEcCtD
Hyoscyamine—Hypotension—Ramipril—type 2 diabetes mellitus	9.97e-05	0.000519	CcSEcCtD
Hyoscyamine—Nausea—Gliclazide—type 2 diabetes mellitus	9.95e-05	0.000518	CcSEcCtD
Hyoscyamine—Pruritus—Metformin—type 2 diabetes mellitus	9.91e-05	0.000516	CcSEcCtD
Hyoscyamine—Urticaria—Losartan—type 2 diabetes mellitus	9.89e-05	0.000515	CcSEcCtD
Hyoscyamine—Abdominal pain—Losartan—type 2 diabetes mellitus	9.84e-05	0.000512	CcSEcCtD
Hyoscyamine—Body temperature increased—Losartan—type 2 diabetes mellitus	9.84e-05	0.000512	CcSEcCtD
Hyoscyamine—Vomiting—Valsartan—type 2 diabetes mellitus	9.78e-05	0.00051	CcSEcCtD
Hyoscyamine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	9.74e-05	0.000507	CcSEcCtD
Hyoscyamine—Rash—Valsartan—type 2 diabetes mellitus	9.7e-05	0.000505	CcSEcCtD
Hyoscyamine—Dermatitis—Valsartan—type 2 diabetes mellitus	9.69e-05	0.000505	CcSEcCtD
Hyoscyamine—Vomiting—Orlistat—type 2 diabetes mellitus	9.67e-05	0.000504	CcSEcCtD
Hyoscyamine—Insomnia—Ramipril—type 2 diabetes mellitus	9.65e-05	0.000503	CcSEcCtD
Hyoscyamine—Headache—Valsartan—type 2 diabetes mellitus	9.64e-05	0.000502	CcSEcCtD
Hyoscyamine—Diarrhoea—Metformin—type 2 diabetes mellitus	9.59e-05	0.000499	CcSEcCtD
Hyoscyamine—Rash—Orlistat—type 2 diabetes mellitus	9.59e-05	0.000499	CcSEcCtD
Hyoscyamine—Dermatitis—Orlistat—type 2 diabetes mellitus	9.58e-05	0.000499	CcSEcCtD
Hyoscyamine—Headache—Orlistat—type 2 diabetes mellitus	9.53e-05	0.000496	CcSEcCtD
Hyoscyamine—Dyspnoea—Ramipril—type 2 diabetes mellitus	9.51e-05	0.000495	CcSEcCtD
Hyoscyamine—Asthenia—Irbesartan—type 2 diabetes mellitus	9.49e-05	0.000494	CcSEcCtD
Hyoscyamine—Somnolence—Ramipril—type 2 diabetes mellitus	9.49e-05	0.000494	CcSEcCtD
Hyoscyamine—Dyspepsia—Ramipril—type 2 diabetes mellitus	9.39e-05	0.000489	CcSEcCtD
Hyoscyamine—Pruritus—Irbesartan—type 2 diabetes mellitus	9.36e-05	0.000487	CcSEcCtD
Hyoscyamine—Dizziness—Metformin—type 2 diabetes mellitus	9.27e-05	0.000483	CcSEcCtD
Hyoscyamine—Fatigue—Ramipril—type 2 diabetes mellitus	9.2e-05	0.000479	CcSEcCtD
Hyoscyamine—Hypersensitivity—Losartan—type 2 diabetes mellitus	9.17e-05	0.000478	CcSEcCtD
Hyoscyamine—Nausea—Valsartan—type 2 diabetes mellitus	9.14e-05	0.000476	CcSEcCtD
Hyoscyamine—Constipation—Ramipril—type 2 diabetes mellitus	9.12e-05	0.000475	CcSEcCtD
Hyoscyamine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	9.05e-05	0.000471	CcSEcCtD
Hyoscyamine—Nausea—Orlistat—type 2 diabetes mellitus	9.03e-05	0.00047	CcSEcCtD
Hyoscyamine—Asthenia—Losartan—type 2 diabetes mellitus	8.93e-05	0.000465	CcSEcCtD
Hyoscyamine—Vomiting—Metformin—type 2 diabetes mellitus	8.91e-05	0.000464	CcSEcCtD
Hyoscyamine—Rash—Metformin—type 2 diabetes mellitus	8.83e-05	0.00046	CcSEcCtD
Hyoscyamine—Dermatitis—Metformin—type 2 diabetes mellitus	8.83e-05	0.00046	CcSEcCtD
Hyoscyamine—Pruritus—Losartan—type 2 diabetes mellitus	8.8e-05	0.000459	CcSEcCtD
Hyoscyamine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	8.79e-05	0.000458	CcSEcCtD
Hyoscyamine—Headache—Metformin—type 2 diabetes mellitus	8.78e-05	0.000457	CcSEcCtD
Hyoscyamine—Dizziness—Irbesartan—type 2 diabetes mellitus	8.74e-05	0.000455	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	8.73e-05	0.000454	CcSEcCtD
Hyoscyamine—Diarrhoea—Losartan—type 2 diabetes mellitus	8.51e-05	0.000443	CcSEcCtD
Hyoscyamine—Urticaria—Ramipril—type 2 diabetes mellitus	8.48e-05	0.000442	CcSEcCtD
Hyoscyamine—Body temperature increased—Ramipril—type 2 diabetes mellitus	8.44e-05	0.000439	CcSEcCtD
Hyoscyamine—Abdominal pain—Ramipril—type 2 diabetes mellitus	8.44e-05	0.000439	CcSEcCtD
Hyoscyamine—Vomiting—Irbesartan—type 2 diabetes mellitus	8.41e-05	0.000438	CcSEcCtD
Hyoscyamine—Rash—Irbesartan—type 2 diabetes mellitus	8.34e-05	0.000434	CcSEcCtD
Hyoscyamine—Dermatitis—Irbesartan—type 2 diabetes mellitus	8.33e-05	0.000434	CcSEcCtD
Hyoscyamine—Nausea—Metformin—type 2 diabetes mellitus	8.32e-05	0.000433	CcSEcCtD
Hyoscyamine—Headache—Irbesartan—type 2 diabetes mellitus	8.28e-05	0.000431	CcSEcCtD
Hyoscyamine—Dizziness—Losartan—type 2 diabetes mellitus	8.23e-05	0.000429	CcSEcCtD
Hyoscyamine—Vomiting—Losartan—type 2 diabetes mellitus	7.91e-05	0.000412	CcSEcCtD
Hyoscyamine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.86e-05	0.000409	CcSEcCtD
Hyoscyamine—Nausea—Irbesartan—type 2 diabetes mellitus	7.85e-05	0.000409	CcSEcCtD
Hyoscyamine—Rash—Losartan—type 2 diabetes mellitus	7.85e-05	0.000409	CcSEcCtD
Hyoscyamine—Dermatitis—Losartan—type 2 diabetes mellitus	7.84e-05	0.000408	CcSEcCtD
Hyoscyamine—Headache—Losartan—type 2 diabetes mellitus	7.8e-05	0.000406	CcSEcCtD
Hyoscyamine—Asthenia—Ramipril—type 2 diabetes mellitus	7.66e-05	0.000399	CcSEcCtD
Hyoscyamine—Pruritus—Ramipril—type 2 diabetes mellitus	7.55e-05	0.000393	CcSEcCtD
Hyoscyamine—Nausea—Losartan—type 2 diabetes mellitus	7.39e-05	0.000385	CcSEcCtD
Hyoscyamine—Diarrhoea—Ramipril—type 2 diabetes mellitus	7.3e-05	0.00038	CcSEcCtD
Hyoscyamine—Dizziness—Ramipril—type 2 diabetes mellitus	7.06e-05	0.000368	CcSEcCtD
Hyoscyamine—Vomiting—Ramipril—type 2 diabetes mellitus	6.78e-05	0.000353	CcSEcCtD
Hyoscyamine—Rash—Ramipril—type 2 diabetes mellitus	6.73e-05	0.00035	CcSEcCtD
Hyoscyamine—Dermatitis—Ramipril—type 2 diabetes mellitus	6.72e-05	0.00035	CcSEcCtD
Hyoscyamine—Headache—Ramipril—type 2 diabetes mellitus	6.68e-05	0.000348	CcSEcCtD
Hyoscyamine—Nausea—Ramipril—type 2 diabetes mellitus	6.34e-05	0.00033	CcSEcCtD
Hyoscyamine—CHRM2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.42e-05	0.000214	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.42e-05	0.000214	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.42e-05	0.000214	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.42e-05	0.000214	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.42e-05	0.000213	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.41e-05	0.000213	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.4e-05	0.000211	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.4e-05	0.000211	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.4e-05	0.00021	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.39e-05	0.00021	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.39e-05	0.00021	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.39e-05	0.000209	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.39e-05	0.000209	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.38e-05	0.000208	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.38e-05	0.000207	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.38e-05	0.000207	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.37e-05	0.000206	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.37e-05	0.000206	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.36e-05	0.000205	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.36e-05	0.000205	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.36e-05	0.000205	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.36e-05	0.000205	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.36e-05	0.000205	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.35e-05	0.000204	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.35e-05	0.000203	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.35e-05	0.000203	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.35e-05	0.000203	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.34e-05	0.000202	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.34e-05	0.000201	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.33e-05	0.0002	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.31e-05	0.000197	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—C3—type 2 diabetes mellitus	1.31e-05	0.000197	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.31e-05	0.000197	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.29e-05	0.000195	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.28e-05	0.000193	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—GNB3—type 2 diabetes mellitus	1.28e-05	0.000193	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—HMOX1—type 2 diabetes mellitus	1.28e-05	0.000192	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.27e-05	0.000191	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.27e-05	0.00019	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.26e-05	0.00019	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.26e-05	0.00019	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CAT—type 2 diabetes mellitus	1.26e-05	0.00019	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.25e-05	0.000189	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—GCG—type 2 diabetes mellitus	1.25e-05	0.000188	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.25e-05	0.000188	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.25e-05	0.000188	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.25e-05	0.000188	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.24e-05	0.000187	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—GCG—type 2 diabetes mellitus	1.24e-05	0.000187	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.24e-05	0.000187	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AGT—type 2 diabetes mellitus	1.24e-05	0.000187	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—GCG—type 2 diabetes mellitus	1.23e-05	0.000185	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.23e-05	0.000185	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.23e-05	0.000185	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.22e-05	0.000184	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.22e-05	0.000184	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—APOB—type 2 diabetes mellitus	1.22e-05	0.000184	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.22e-05	0.000184	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.22e-05	0.000184	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—APOE—type 2 diabetes mellitus	1.22e-05	0.000183	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—LEP—type 2 diabetes mellitus	1.22e-05	0.000183	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.21e-05	0.000182	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.21e-05	0.000182	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.2e-05	0.000181	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—GSTM1—type 2 diabetes mellitus	1.19e-05	0.000179	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.17e-05	0.000176	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—LPL—type 2 diabetes mellitus	1.17e-05	0.000176	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.16e-05	0.000175	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.15e-05	0.000174	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.15e-05	0.000173	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.15e-05	0.000173	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.15e-05	0.000173	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.14e-05	0.000172	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—ADCY5—type 2 diabetes mellitus	1.14e-05	0.000172	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.14e-05	0.000172	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—GPX1—type 2 diabetes mellitus	1.14e-05	0.000171	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.13e-05	0.00017	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.13e-05	0.00017	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CD36—type 2 diabetes mellitus	1.11e-05	0.000167	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PPP2CA—type 2 diabetes mellitus	1.1e-05	0.000165	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.09e-05	0.000163	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.09e-05	0.000163	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.08e-05	0.000163	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.08e-05	0.000162	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.07e-05	0.000161	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.07e-05	0.000161	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.06e-05	0.00016	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.06e-05	0.00016	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.06e-05	0.00016	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AVP—type 2 diabetes mellitus	1.06e-05	0.000159	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.06e-05	0.000159	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.06e-05	0.000159	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.05e-05	0.000158	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.05e-05	0.000158	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—MTHFR—type 2 diabetes mellitus	1.05e-05	0.000158	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.05e-05	0.000158	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	1.05e-05	0.000158	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.05e-05	0.000158	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.04e-05	0.000157	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.04e-05	0.000157	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—INS—type 2 diabetes mellitus	1.04e-05	0.000157	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.04e-05	0.000156	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.04e-05	0.000156	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PPARA—type 2 diabetes mellitus	1.03e-05	0.000155	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.03e-05	0.000155	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.03e-05	0.000154	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.02e-05	0.000154	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—APOB—type 2 diabetes mellitus	1.02e-05	0.000154	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.02e-05	0.000154	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.02e-05	0.000153	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	1.01e-05	0.000152	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.01e-05	0.000152	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.01e-05	0.000152	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.01e-05	0.000151	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.01e-05	0.000151	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.01e-05	0.000151	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1e-05	0.000151	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—AGT—type 2 diabetes mellitus	9.99e-06	0.00015	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	9.96e-06	0.00015	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CALM1—type 2 diabetes mellitus	9.82e-06	0.000148	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	9.79e-06	0.000147	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—APOE—type 2 diabetes mellitus	9.79e-06	0.000147	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—LPL—type 2 diabetes mellitus	9.76e-06	0.000147	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—APOA1—type 2 diabetes mellitus	9.67e-06	0.000146	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	9.67e-06	0.000145	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.59e-06	0.000144	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.56e-06	0.000144	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.55e-06	0.000144	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.46e-06	0.000142	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.19e-06	0.000138	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.16e-06	0.000138	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.12e-06	0.000137	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.12e-06	0.000137	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.07e-06	0.000137	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.02e-06	0.000136	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.99e-06	0.000135	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.91e-06	0.000134	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—C3—type 2 diabetes mellitus	8.82e-06	0.000133	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—C3—type 2 diabetes mellitus	8.79e-06	0.000132	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	8.7e-06	0.000131	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—RELA—type 2 diabetes mellitus	8.59e-06	0.000129	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PPARG—type 2 diabetes mellitus	8.52e-06	0.000128	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.41e-06	0.000127	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.39e-06	0.000126	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.38e-06	0.000126	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	8.38e-06	0.000126	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.36e-06	0.000126	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—INS—type 2 diabetes mellitus	8.36e-06	0.000126	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	8.35e-06	0.000126	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.3e-06	0.000125	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.28e-06	0.000125	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	8.27e-06	0.000124	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.24e-06	0.000124	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.21e-06	0.000124	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	8.21e-06	0.000124	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	8.21e-06	0.000124	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	8.18e-06	0.000123	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	8.18e-06	0.000123	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.13e-06	0.000122	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.12e-06	0.000122	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	8.1e-06	0.000122	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	8.1e-06	0.000122	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.09e-06	0.000122	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.01e-06	0.000121	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.82e-06	0.000118	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.74e-06	0.000117	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.74e-06	0.000117	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.72e-06	0.000116	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.69e-06	0.000116	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	7.66e-06	0.000115	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.64e-06	0.000115	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	7.33e-06	0.00011	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	7.33e-06	0.00011	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.32e-06	0.00011	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.32e-06	0.00011	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.3e-06	0.00011	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.24e-06	0.000109	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.23e-06	0.000109	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.1e-06	0.000107	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	7.01e-06	0.000106	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	6.99e-06	0.000105	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	6.92e-06	0.000104	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.9e-06	0.000104	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.88e-06	0.000104	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.81e-06	0.000103	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.78e-06	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.78e-06	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.76e-06	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.76e-06	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.75e-06	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—SRC—type 2 diabetes mellitus	6.75e-06	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.73e-06	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	6.71e-06	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.7e-06	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.69e-06	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.66e-06	0.0001	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.57e-06	9.89e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.44e-06	9.69e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.42e-06	9.66e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.36e-06	9.57e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.15e-06	9.26e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.15e-06	9.26e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.13e-06	9.23e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.13e-06	9.23e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.07e-06	9.14e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.07e-06	9.14e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.03e-06	9.08e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.91e-06	8.9e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	5.79e-06	8.71e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	5.77e-06	8.68e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	5.71e-06	8.6e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.27e-06	7.93e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.25e-06	7.91e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.22e-06	7.86e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.2e-06	7.83e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.2e-06	7.83e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.19e-06	7.81e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.17e-06	7.78e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.15e-06	7.76e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.12e-06	7.71e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.93e-06	7.43e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.92e-06	7.4e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.88e-06	7.35e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.87e-06	7.33e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.87e-06	7.32e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.82e-06	7.25e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.79e-06	7.2e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.77e-06	7.18e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.72e-06	7.11e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.55e-06	6.85e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IL6—type 2 diabetes mellitus	4.54e-06	6.84e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	4.53e-06	6.82e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	4.49e-06	6.76e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.43e-06	6.67e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.42e-06	6.65e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.37e-06	6.58e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.19e-06	6.31e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.07e-06	6.12e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.05e-06	6.1e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.01e-06	6.04e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.99e-06	6e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.97e-06	5.98e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.94e-06	5.92e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	3.37e-06	5.07e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.06e-06	4.61e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	3.05e-06	4.6e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	3.02e-06	4.55e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.83e-06	4.25e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.82e-06	4.24e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.79e-06	4.2e-05	CbGpPWpGaD
